Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Selectis Health (GBCS) EBIAT (2017 - 2025)

Selectis Health's EBIAT history spans 14 years, with the latest figure at $752365.0 for Q3 2025.

  • For Q3 2025, EBIAT rose 146.81% year-over-year to $752365.0; the TTM value through Sep 2025 reached -$788094.0, up 85.62%, while the annual FY2024 figure was -$2.4 million, 38.96% up from the prior year.
  • EBIAT for Q3 2025 was $752365.0 at Selectis Health, up from -$308027.0 in the prior quarter.
  • Across five years, EBIAT topped out at $4.0 million in Q1 2023 and bottomed at -$3.6 million in Q4 2023.
  • The 5-year median for EBIAT is -$655969.0 (2025), against an average of -$592335.1.
  • The largest annual shift saw EBIAT crashed 1769.95% in 2022 before it skyrocketed 10752.46% in 2023.
  • A 5-year view of EBIAT shows it stood at -$1.8 million in 2021, then fell by 23.23% to -$2.2 million in 2022, then tumbled by 65.73% to -$3.6 million in 2023, then surged by 84.13% to -$576463.0 in 2024, then skyrocketed by 230.51% to $752365.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's EBIAT are $752365.0 (Q3 2025), -$308027.0 (Q2 2025), and -$655969.0 (Q1 2025).